Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 39 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PULSE BIOSCIENCES, INC. | 48,211,433 | reported | 11 May 2026 | tx 159+59,885,549−11,655,302 |
| Achaogen Inc | 5,555,414 | reported | 20 Mar 2019 | tx 40+3,809,824−3,631,895 |
| Summit Therapeutics Inc. | 11,232 | reported | 02 Jan 2026 | tx 23+552,985,344−74,545 |
| INTUITIVE SURGICAL INC | 0 | reported | 18 May 2011 | tx 454+118,866−1,039,712 |
| PHARMACYCLICS INC | 0 | reported | 26 May 2015 | tx 230+14,344,763−19,781,715 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | PURCHASE | PULSE BIOSCIENCES, INC. | 660,233 | 19.69 USD | |
| 02 Jan 2026 | GRANT_AWARD | Summit Therapeutics Inc. | 11,232 | 8.76 USD | deriv |
| 21 Oct 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 266,808 | 18.74 USD | |
| 21 Oct 2025 | PURCHASE | Summit Therapeutics Inc. | 26,680 | 18.74 USD | |
| 21 Oct 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 13,980,789 | 18.74 USD | |
| 11 Sept 2024 | PURCHASE | PULSE BIOSCIENCES, INC. | 12,800 | 14.77 USD | |
| 12 Sept 2024 | PURCHASE | PULSE BIOSCIENCES, INC. | 145,140 | 14.41 USD | |
| 10 Sept 2025 | PURCHASE | PULSE BIOSCIENCES, INC. | 34,659 | 14.66 USD | |
| 10 Sept 2025 | PURCHASE | Summit Therapeutics Inc. | 333,394 | 17.68 USD | |
| 11 Sept 2025 | PURCHASE | Summit Therapeutics Inc. | 5,000 | 18.07 USD | |
| 15 Aug 2025 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 20,792 | 0.00 USD | deriv |
| 15 Aug 2025 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 30,000 | 0.00 USD | deriv |
| 30 May 2025 | EXERCISE | Summit Therapeutics Inc. | 74,545 | 2.64 USD | |
| 30 May 2025 | EXERCISE | Summit Therapeutics Inc. | 74,545 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 9,590,558 | — | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 400,000 | — | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 1,040,000 | — | deriv |
| 08 Apr 2025 | EXERCISE | Summit Therapeutics Inc. | 3,985,055 | 1.58 USD | |
| 08 Apr 2025 | EXERCISE | Summit Therapeutics Inc. | 3,985,055 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 10,724 | 9.18 USD | deriv |
| 18 Dec 2024 | EXERCISE | PULSE BIOSCIENCES, INC. | 5,187,824 | 11.00 USD | |
| 18 Dec 2024 | EXERCISE | PULSE BIOSCIENCES, INC. | 69,020 | 11.00 USD | |
| 18 Dec 2024 | EXERCISE | PULSE BIOSCIENCES, INC. | 49,312 | 11.00 USD | |
| 18 Dec 2024 | EXERCISE | PULSE BIOSCIENCES, INC. | 2,593,912 | — | deriv |
| 18 Dec 2024 | EXERCISE | PULSE BIOSCIENCES, INC. | 34,510 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 15 Jun 2020.